Abstract
Neutral lipids have been implicated in a host of potentially debilitating human diseases, such as heart disease, type-2 diabetes, and metabolic syndrome. Matrix-assisted laser desorption ionization (MALDI), the method-of-choice for mass spectrometry imaging (MSI), has led to remarkable success in imaging several lipid classes from biological tissue sections. However, due to ion suppression by phospholipids, MALDI has limited ability to efficiently ionize and image neutral lipids, such as triglycerides (TGs). To help overcome this obstacle, we have utilized silicon nanopost arrays (NAPA), a matrix-free laser desorption ionization (LDI) platform. Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease of the apocrine sweat glands. The ability of NAPA to efficiently ionize lipids is exploited in the analysis of human skin samples from sufferers of HS. Ionization by LDI from NAPA allows for the detection and imaging of a number of neutral lipid species, including TGs comprised of shorter, odd-chain fatty acids, which strongly suggests an increased bacterial load within the host tissue, as well as hexosylceramides (HexCers) and galabiosyl-/lactosylceramides that appear to be correlated with the presence of HS. Our results demonstrate that NAPA-LDI-MSI is capable of imaging and potentially differentiating healthy and diseased human skin tissues based on changes in detected neutral lipid composition.
Subject terms: Imaging studies, Mass spectrometry, Medical and clinical diagnostics
Introduction
Lipids are a diverse class of biological compounds that play numerous roles in human physiology and disease. In addition to serving as the main building blocks of cell membranes, they are involved in a host of critical biological processes such as cell-to-cell signaling and energy storage1. Lipids constitute over half of the brain’s dry weight, and changes in certain lipid classes such as hexosylceramides (HexCers) and phosphatidylethanolamines (PEs) have been implicated in devastating neurological diseases, such as Alzheimer’s disease2–5. Neutral lipids, for example, triglycerides (TGs), diglycerides (DGs), and monoglycerides (MGs), steryl esters (SEs), and wax esters (WEs), are essential in energy storage but some of them, e.g., DGs, also function as second messengers in lipid signaling, and help to maintain sterol homeostasis (e.g., SEs)6–8.
With its ability to simultaneously provide detailed chemical information and reveal spatial distributions of analytes within tissue, mass spectrometry imaging (MSI) has the potential to provide significant insight into the roles of lipids in maintaining homeostasis and the development of disease. Imaging by mass spectrometry is an analytical technique that can detect and identify biomolecules with high chemical specificity, while simultaneously mapping their spatial distributions within biological tissue sections. Driven by this unique set of capabilities, MSI has seen widespread growth in fields such as the pharmaceutical industry and clinical diagnostics9–12. Matrix-assisted laser desorption ionization (MALDI) and secondary ion mass spectrometry (SIMS) were the first MSI platforms to capture the distributions of diverse chemical species in biological tissues13,14. Since then, MALDI, in which a UV-absorbing matrix is deposited onto the sample to facilitate laser desorption ionization (LDI), has become the most extensively used MSI platform. The widespread adoption of MALDI-MSI can be attributed in large part to the wide array of possible matrices, many of which provide selective ionization of certain compounds or classes of compounds9,15,16. This versatility has allowed for the imaging of a broad range of biomolecules including proteins, peptides, metabolites, and lipids17–21.
Despite the rapid advancements in the application of MALDI for MSI and the development of novel MALDI matrices, many challenges remain. Notably, MSI of neutral lipids, such as TGs, has been difficult using organic MALDI matrices, for example, 2,5-dihydroxybenzoic acid (DHB), due to ion suppression by phospholipids, e.g., phosphatidylcholines (PCs). To overcome this limitation, several novel methods, incorporating metal nanoparticles in place of organic matrices, have been developed facilitating the detection and imaging of TGs in the presence of PCs22–24. While these modifications have helped to extend the attainable lipid coverage in MALDI-MSI experiments, they still require deposition of a UV-absorbing material onto the tissue for MSI. This process can lead to inhomogeneous matrix deposition, diffusion of analytes, and creation of so-called “hot spots”, which negatively affect the achievable spatial resolution and can disrupt localization of analytes15,25–27.
Since the emergence of MALDI-MSI, several innovative matrix-free MSI platforms such as nanostructure-initiator mass spectrometry (NIMS), desorption/ionization on silicon (DIOS), desorption electrospray ionization (DESI), and laser ablation electrospray ionization (LAESI) have been developed. These techniques were developed for or adapted to imaging with the goals of circumventing the low mass interference introduced by the MALDI matrix, minimizing sample preparation, and extending the attainable molecular coverage for MSI applications28–36. Another matrix-free platform capable of MSI, LDI from silicon nanopost arrays (NAPA), was developed in our lab. It has been shown to provide ultra-trace sensitivity and the detection of a wide range of compounds and compound classes37–40. Previous MSI experiments examining mouse brain tissue sections on NAPA revealed enhanced ionization efficiency for certain lipid classes, such as HexCers and PEs, when compared to MALDI41. This enhanced sensitivity for difficult-to-detect species in tissues offers the possibility of using NAPA-MS to complement MALDI-MS for studying the roles of neutral lipids and other lipid classes in biological processes and disease.
For many years, antibiotics have been the first-line therapy for HS, however, routine cultures of HS lesions often fail to identify infection, or identify predominantly skin flora42,43. As genomic technologies have become more advanced, 16 S ribosomal RNA techniques have been used to study the HS microbiome and the mechanisms by which microbial dysbiosis contribute to disease development in HS43. Previous investigations of HS cases have established that patients have increased bacterial loads in affected areas, where it has been hypothesized that the infection is a result of the malfunctioning hair follicle and apocrine sweat gland region44–47. Anaerobes, in particular Prevotella (17.5%), Porphyromonas (6.2%), and Fusobacterium (10.3%), predominate in HS lesions47. When HS lesions become advanced, bacterial biofilms may contribute to disease pathogenesis, however, the mechanisms by which biofilms contribute to HS disease progression and the interactions between biofilms and the host immune response are poorly understood48,49.
The ability of NAPA-LDI-MSI to directly measure relevant chemical species with high spatial resolution makes it a promising platform for the study of host-pathogen interactions in systems such as HS-affected skin tissue. Here, we present the use of NAPA-LDI-MSI for imaging of neutral lipid distributions in human skin tissue. To illustrate potential medical applications, we apply NAPA-LDI-MSI to study lipid profiles and localizations in skin samples obtained from patients diagnosed with Hidradenitis suppurativa (HS), a chronic skin disease that causes inflammation and seriously compromises quality of life for many sufferers.
Results
To account for natural variation of lipid distributions within tissue sections, comparisons between control and Hidradenitis suppurativa tissues were constrained to two distinct regions identified by tissue morphology and confirmed by subsequently identified biomarkers. The first region used for comparisons consisted of the region surrounding the hair follicle and apocrine sweat gland, whereas the second region consisted of dermis tissue distant from these two features. Principal component analysis (PCA) of spectra obtained from the follicle/apocrine sweat gland region of control and HS skin sections allowed for the distinction of the two sample types (see the scores plot in Fig. 1a, and the loading plots in Supplementary Fig. S1 and Supplementary Table 1. Contributions of tentatively identified ions by lipid classes are color coded in the loading plots). A total of 170 ion signals were detected with significantly different ion intensities between HS and control tissues at fold-change, FC = IHS/IC, and p-value thresholds of FC > 2 or FC < 1/2 and p < 0.05, respectively (Fig. 1b). Subsequent identification of ion signals by accurate m/z search against a lipid database (LIPID MAPS; www.lipidmaps.org) and tandem MS analysis revealed a number of triglycerides (TGs) comprised of shorter, odd-chain fatty acids (C15:0, C13:0, etc.) to be significantly more abundant in HS tissue than the control (see Supplementary Table 2). These species exhibited fold increases in signal intensity ranging from 2 to 16 for HS tissue relative to the control. In contrast, TGs containing exclusively even-chain fatty acids (C16:0, C18:0, etc.) were detected more weakly in HS samples, with signal intensity fold decreases, −1/FC, ranging from −2 to −48 compared to control tissue (see Supplementary Table 2). Other tentatively assigned ions (i.e., from accurate m/z alone) representing neutral lipid classes, such as DGs, MGs, and WEs showed fold increases in signal intensity ranging from 13 to 37 for HS tissue compared to control.
Comparison of the dermis region of control and HS tissue analyzed by NAPA-LDI-MSI revealed even greater separation of the two tissue types by PCA (see the scores plot in Fig. 1c and the loadings in Supplementary Table 1). A total of 350 ion signals were detected with significantly different intensities between HS and control tissues at the same significance criteria (Fig. 1d). Subsequent identification revealed several members of another class of neutral lipids, hexosylceramides (HexCers) and galabiosyl-/lactosylceramides, to contribute significantly to the difference between the two tissue types. For HS diseased tissue, a statistically significant increase in the detection of galabiosyl-/lactosylceramides was observed within the dermis, with average fold increases ranging from 29 to 403. As with the hair follicle/apocrine sweat gland region, the lipids decreased in the HS diseased tissue consisted largely of TGs containing exclusively even-chain fatty acids, with average fold decreases, −1/FC, ranging from −6 to −22. Additionally, a significant increase of the tentatively assigned lipid species lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) was observed in the dermis region of HS tissue, with an average fold increase ranging from 9 to 42.
Following identification of species contributing to differences between HS and control tissues, MS images were generated to examine the distribution of these species within the tissue samples. Figure 2 presents the spatial distributions of several TGs varying by one carbon. TGs containing odd-carbon or short-chain fatty acids (43:0, 44:0, 45:0, and 47:0) were predominantly localized to the hair follicle/apocrine sweat gland region. Sample tandem MS spectra used for identification of these species are presented in Supplementary Fig. S2. Those containing longer-chain, even-carbon fatty acids were distributed more uniformly throughout the tissue. When comparing mass spectra (see Fig. 2), TGs consisting of shorter, odd-chain fatty acids found in the m/z 700–815 range were found to dominate the spectrum for HS tissue, whereas TGs consisting of longer, even-chain fatty acids found in the m/z 820–950 range were found to dominate the spectrum from control tissue. Moreover, MS images for one sulfatide (SHexCer) and several galabiosyl-/lactosylceramides can be found in Fig. 3. The galabiosyl-/lactosylceramides in particular were detected throughout the epidermis of HS tissues and were almost completely absent in control samples. This was further illustrated when comparing the mass spectra, as lipid classes such as galabiosyl-/lactosylceramides, HexCers, and phospholipids dominated the mass spectrum for HS diseased tissue, whereas native-like TGs consisting of longer, even-chain fatty acids dominated the control spectrum. Sample tandem MS spectra used for identification of these species are presented in Supplementary Fig. S3.
Discussion
Based on the ability of mapping neutral lipid distributions in human tissue by NAPA-LDI-MSI, our results help explore the localization of bacteria in HS affected skin. This is possible given that bacteria have been shown to be the primary source of odd-carbon number and short-chain fatty acids in mammalian tissues, where they are not natively produced in significant quantities50–56. We therefore hypothesize that the increased abundance of these lipids observed in HS-infected tissue is a result of increased bacterial load. Moreover, the apparently localized accumulation of these lipids (2 to 16-fold increase in HS near the hair follicles relative to control) is consistent with this observation. To confirm the localized increase in bacterial load, HS and control tissue samples (Fig. 4) were examined by scanning electron microscopy (SEM). In the control tissue sample (Fig. 4c,e), small colonies of bacteria were visible along the hair shaft. Given the ubiquity of bacteria on human skin and the critical roles the skin microflora plays in maintaining overall health, this finding was expected. In contrast, the hair shaft of the HS diseased tissue (Fig. 4d,f) showed a substantially greater number of bacteria forming contiguous sheets along the hair follicle. Moreover, significant accumulation of what appear to be immune cells (Fig. 5) was observed in the epidermis of HS diseased tissue (Fig. 5d), whereas they were absent in the control (Fig. 5c), indicating an immune response from the host tissue to bacterial infection. SEM imaging of tissue punches from HS diseased tissue also revealed a characteristic fistula, a hallmark of HS (See Supplementary Fig. S4b).
The significantly higher levels of galabiosyl-/lactosylceramides detected from HS diseased tissue by NAPA-LDI-MSI, as well as the apparent accumulation of immune cells in the HS diseased epidermis, support previous findings that accumulation of bacteria is associated with HS. Sphingolipids, for example galabiosyl-/lactosylceramides, are a class of neutral lipids that have been shown to be involved in a host of physiological processes, such as cellular stress response, apoptosis, cell proliferation, and microbial pathogenesis57–60. Certain sphingolipids have been shown to possess antibacterial activity toward specific bacterial strains, contributing to defense against pathogenic bacteria61–65. Furthermore, glycosphingolipids, such as lactosylceramides (LacCers), have become an area of research interest, as they have been shown to be involved in mediating innate immune responses, host-tissue pathogen interactions, and chronic inflammatory diseases66–68. The ability of LacCers to form “lipid rafts” within the cell membrane of host-tissue neutrophils confers binding selectivity against certain strains of bacteria, helping to target harmful pathogens69. The significant increase in galabiosyl-/lactosylceramides observed here is in agreement with the finding that enzymes responsible for generation of galabiosylceramides were significantly elevated in HS patients, although the isomeric galabiosyl- and lactosylceramides could not be distinguished in this work70. Lastly, the significantly increased intensity of ions tentatively assigned as LPA and S1P, both previously shown to help regulate immunity, cindicates the potential of using this technique for further study into the dynamics of the host tissue-pathogen interaction71,72.
As a matrix-free LDI-MSI platform offering enhanced ionization efficiency for classes of neutral lipids, e.g., TGs and sphingolipids, NAPA structures expand the coverage of lipid classes present in biological tissues. Serving as a complementary MSI platform, NAPA can be used in conjunction with MALDI, whereby imaging of different lipid classes from serial tissue sections can provide further insight into human diseases, such as heart disease and metabolic syndrome, as well as host-pathogen interactions. Given that neutral lipids have become a growing area of interest in biomedical research, the ability to detect and spatially map their distributions in biological tissues contributes to advancing this burgeoning field.
Conclusion
Here we have shown an application of the NAPA-LDI-MSI platform to analyze and differentiate between control and HS diseased human skin tissue samples through differences in the observed lipid composition. The ability of NAPA to selectively ionize neutral lipid classes, such as TGs and galabiosyl-/lactosylceramides—lipid species that serve critical functions in numerous biological processes and are often difficult to detect in conventional MALDI-MSI—presents the possibility of using this platform to further investigate host-pathogen relationships, the process of pathogenesis, and defense mechanisms against infection.
Methods
Chemicals and materials
LC-MS grade water (catalog no. W6–212) and chloroform (catalog no. C6704–4) were purchased from Fisher Scientific (Hampton, NH). Carboxymethylcellulose (CMC; catalog no. C4888) was purchased from Sigma-Aldrich (St. Louis, MO). Lipid standard D-lactosyl-ß-1,1′ N-palmitoyl-D-erythro-sphingosine (LacCer(d34:1), catalog no. 860576 P) was purchased from Avanti Polar Lipids, Inc. (Alabaster, AL). SEM reagents glutaraldehyde (catalog no. 16020), paraformaldehyde (catalog no. 15710), sodium cacodylate buffer (catalog no. 11652), anhydrous ethanol (catalog no. 15055), and osmium tetroxide (catalog no. 19170) were all purchased from Electron Microscopy Sciences (Hatfield, PA). Conductive silver paint (catalog no.16062) was purchased from Ted Pella, Inc. (Redding, CA).
Fabrication of NAPA imaging chips
The complete fabrication process for production of NAPA imaging chips has been previously described73. Briefly, NAPA imaging wafers were produced from low resistivity p-type silicon wafers using deep UV projection lithography (DUV-PL) followed by deep reactive ion etching (DRIE). Final dimensions for nanoposts were 1100 nm in height and 150 nm in diameter, with a periodicity of 337 nm.
Tissue sample prep for MSI
Human skin tissues were harvested from four patients diagnosed with Hurley Stage III HS (diseased tissue) and three patients undergoing abdominoplasty (control tissue) in accordance with protocols approved by the GW Institutional Review Board 041408 and 101419, respectively. All human subjects gave written informed consent for collection of specimens and data, and all methods were performed in accordance with the relevant guidelines and regulations. Tissue samples were collected from the operating room immediately after being excised from the patient and washed with PBS solution before being stored at -80 °C. For cryosectioning, tissue samples were embedded in a 2.5% CMC solution and sectioned at a 5 µm thickness at -25 °C. Tissue sections were then thaw-mounted onto NAPA imaging chips and placed in a desiccator for ~30 min before MSI analysis.
MSI data acquisition and image processing
All MSI analysis of human skin samples on NAPA was performed using a MALDI-LTQ-Orbitrap XL mass spectrometer (Thermo Scientific, San Jose, CA). A nitrogen laser emitting radiation at 337 nm with a focal spot size of ~100 µm × 80 µm was operated at a laser fluence of ~150 mJ/cm2 with 3 laser shots/scan and a raster step size of 100 µm. All mass spectra were acquired from m/z 180 and 1,000 using the orbitrap mass analyzer at a mass resolving power setting of 30,000. After acquisition, all MS images were generated with a m/z tolerance of 5 mDa using the ImageQuest software package (Thermo Scientific). Ion images were smoothed using the linear function.
Scanning electron microscopy
Tissue sections and punches were fixed in a 2.5% glutaraldehyde, 1.5% paraformaldehyde, and 0.12 M sodium cacodylate buffer (pH 7.4) solution for a minimum of 24 h, then rinsed with a 0.12 M sodium cacodylate buffer (pH 7.4) at 3 × 15 min intervals and placed in a 1% OsO4 solution for 1 h. Samples were then dehydrated by subsequent immersion in 9 ethanol-water solutions with increasing concentration (15% up to 100%) at 15 min intervals before immediately being placed in a Tousimis 931 critical point dryer (Tousimis, Rockville, MD). After fixation, samples were mounted onto SEM stubs and sputter coated (Cressington Scientific Instruments, Watford, England) with a 6 nm-thick coating of iridium. All SEM images were acquired using a FEI Teneo LV FEG SEM (Thermo Fisher Scientific, Waltham, MA) with a high voltage of 2 kV and a current of 13 pA.
Data analysis
After acquisition, raw data files (*.raw) were imported into ImageQuest (Thermo Scientific, San Jose, CA) for processing. MS scans from the hair follicle/apocrine sweat gland region and dermis region of both tissue types were averaged and exported, then uploaded into mMass for peak picking and deisotoping74. Principal component analysis was performed using MetaboAnalyst (https://www.metaboanalyst.ca; last visited 12/28/2018). Parameters for performing PCA analysis of the hair follicle/apocrine sweat gland region and dermis region consisted of a 7 mDa mass window for binning of mass spectra, as well as a setting of 65% and 67% missing values threshold, respectively. Furthermore, all data were normalized to the sum, log transformed, and scaled using Pareto scaling. The m/z values identified as statistically significant (p < 0.05) with a signal intensity fold-change between diseased and control greater than 2 were compared against the LipidMaps reference database, (http://www.lipidmaps.org/), for tentative lipid identifications based on mass accuracy (±5 mDa). Finally, confirmation of lipid identifications were carried out using tandem MS with fragmentation induced by collisional induced dissociation (CID). TGs were identified based on observed neutral fatty acid chain losses, whereas galabiosyl-/lactosylceramides were identified based on individual sugar losses, and by spectral comparison to a commercial standard.
Supplementary material
Acknowledgements
Research was sponsored by the U.S. Army Research Office and the Defense Advanced Research Projects Agency and was accomplished under cooperative agreement number W911NF-14–2–0020. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Office, DARPA, or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation hereon.
Author contributions
A. V., V. K. S., and R. K. P. conceived the research. J. A. F., J. E. D., and D. R. J. performed the experiments. P. P., A. P., and C. A. B. assisted with the collection of SEM images. N. J. M. and A. V. participated in the design and development of NAPA nanostructures. J. A. F. performed the data analysis and wrote the manuscript with input from A. V., V. K. S., and A. R. K.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
is available for this paper at 10.1038/s41598-019-53938-0.
References
- 1.Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Reviews Molecular Cell Biology. 2008;9:139–150. doi: 10.1038/nrm2329. [DOI] [PubMed] [Google Scholar]
- 2.Chan RB, et al. Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease. J. Biol. Chem. 2012;287:2678–2688. doi: 10.1074/jbc.M111.274142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Di Paolo G, Kim TW. Linking lipids to Alzheimer’s disease: cholesterol and beyond. Nature Reviews Neuroscience. 2011;12:284–296. doi: 10.1038/nrn3012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Grimm MOW, et al. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer’s disease. J. Neurochem. 2011;116:916–925. doi: 10.1111/j.1471-4159.2010.07070.x. [DOI] [PubMed] [Google Scholar]
- 5.Khan M, Singh J, Singh I. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. J. Neurochem. 2008;106:1766–1779. doi: 10.1111/j.1471-4159.2008.05513.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Korber M, Klein I, Daum G. Steryl ester synthesis, storage and hydrolysis: A contribution to sterol homeostasis. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids. 2017;1862:1534–1545. doi: 10.1016/j.bbalip.2017.09.002. [DOI] [PubMed] [Google Scholar]
- 7.Huang KP. The Mechanism of Protein Kinase-C Activation. Trends Neurosci. 1989;12:425–432. doi: 10.1016/0166-2236(89)90091-x. [DOI] [PubMed] [Google Scholar]
- 8.Athenstaedt K, Daum G. The life cycle of neutral lipids: synthesis, storage and degradation. Cell. Mol. Life Sci. 2006;63:1355–1369. doi: 10.1007/s00018-006-6016-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Buchberger AR, DeLaney K, Johnson J, Li LJ. Mass Spectrometry Imaging: A Review of Emerging Advancements and Future Insights. Anal. Chem. 2018;90:240–265. doi: 10.1021/acs.analchem.7b04733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gowda GAN, et al. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn. 2008;8:617–633. doi: 10.1586/14737159.8.5.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Neubert P, Walch A. Current frontiers in clinical research application of MALDI imaging mass spectrometry. Expert Review of Proteomics. 2013;10:259–273. doi: 10.1586/epr.13.19. [DOI] [PubMed] [Google Scholar]
- 12.Schubert KO, Weiland F, Baune BT, Hoffmann P. The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review. Proteomics. 2016;16:1747–1758. doi: 10.1002/pmic.201500460. [DOI] [PubMed] [Google Scholar]
- 13.Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: Localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 1997;69:4751–4760. doi: 10.1021/ac970888i. [DOI] [PubMed] [Google Scholar]
- 14.Sjovall P, Lausmaa J, Johansson B. Mass spectrometric imaging of lipids in brain tissue. Anal. Chem. 2004;76:4271–4278. doi: 10.1021/ac049389p. [DOI] [PubMed] [Google Scholar]
- 15.Thomas A, Charbonneau JL, Fournaise E, Chaurand P. Sublimation of New Matrix Candidates for High Spatial Resolution Imaging Mass Spectrometry of Lipids: Enhanced Information in Both Positive and Negative Polarities after 1,5-Diaminonapthalene Deposition. Anal. Chem. 2012;84:2048–2054. doi: 10.1021/ac2033547. [DOI] [PubMed] [Google Scholar]
- 16.Fitzgerald MC, Parr GR, Smith LM. BASIC MATRICES FOR THE MATRIX-ASSISTED LASER-DESORPTION IONIZATION MASS-SPECTROMETRY OF PROTEINS AND OLIGONUCLEOTIDES. Analytical Chemistry. 1993;65:3204–3211. doi: 10.1021/ac00070a007. [DOI] [PubMed] [Google Scholar]
- 17.Hutchinson RW, et al. Imaging and spatial distribution of beta-amyloid peptide and metal ions in Alzheimer’s plaques by laser ablation-inductively coupled plasma-mass spectrometry. Anal. Biochem. 2005;346:225–233. doi: 10.1016/j.ab.2005.08.024. [DOI] [PubMed] [Google Scholar]
- 18.Jackson SN, et al. MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue. J. Mass Spectrom. 2007;42:1093–1098. doi: 10.1002/jms.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kertesz V, et al. Comparison of drug distribution images from whole-body thin tissue sections obtained using desorption electrospray ionization tandem mass spectrometry and autoradiography. Anal. Chem. 2008;80:5168–5177. doi: 10.1021/ac800546a. [DOI] [PubMed] [Google Scholar]
- 20.Miura D, et al. Ultrahighly Sensitive in Situ Metabolomic Imaging for Visualizing Spatiotemporal Metabolic Behaviors. Anal. Chem. 2010;82:9789–9796. doi: 10.1021/ac101998z. [DOI] [PubMed] [Google Scholar]
- 21.Seeley EH, Oppenheimer SR, Mi D, Chaurand P, Caprioli RM. Enhancement of protein sensitivity for MALDI imaging mass spectrometry after chemical treatment of tissue sections. J. Am. Soc. Mass. Spectrom. 2008;19:1069–1077. doi: 10.1016/j.jasms.2008.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dufresne M, Masson JF, Chaurand P. Sodium-Doped Gold-Assisted Laser Desorption Ionization for Enhanced Imaging Mass Spectrometry of Triacylglycerols from Thin Tissue Sections. Anal. Chem. 2016;88:6018–6025. doi: 10.1021/acs.analchem.6b01141. [DOI] [PubMed] [Google Scholar]
- 23.Jackson SN, et al. Imaging of lipids in rat heart by MALDI-MS with silver nanoparticles. Anal. Bioanal. Chem. 2014;406:1377–1386. doi: 10.1007/s00216-013-7525-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Son J, Lee G, Cha S. Direct Analysis of Triacylglycerols from Crude Lipid Mixtures by Gold Nanoparticle-Assisted Laser Desorption/Ionization Mass Spectrometry. J. Am. Soc. Mass. Spectrom. 2014;25:891–894. doi: 10.1007/s13361-014-0844-9. [DOI] [PubMed] [Google Scholar]
- 25.Alexandrov, T. MALDI imaging mass spectrometry: statistical data analysis and current computational challenges. BMC Bioinformatics, 13, 10.1186/1471-2105-13-s16-s11 (2012). [DOI] [PMC free article] [PubMed]
- 26.Baluya DL, Garrett TJ, Yost RA. Automated MALDI matrix deposition method with inkjet printing for imaging mass spectrometry. Anal. Chem. 2007;79:6862–6867. doi: 10.1021/ac070958d. [DOI] [PubMed] [Google Scholar]
- 27.Goodwin RJA. Sample preparation for mass spectrometry imaging: Small mistakes can lead to big consequences. J. Proteomics. 2012;75:4893–4911. doi: 10.1016/j.jprot.2012.04.012. [DOI] [PubMed] [Google Scholar]
- 28.Nemes P, Vertes A. Laser ablation electrospray ionization for atmospheric pressure, in vivo, and imaging mass spectrometry. Anal. Chem. 2007;79:8098–8106. doi: 10.1021/ac071181r. [DOI] [PubMed] [Google Scholar]
- 29.Northen TR, et al. Clathrate nanostructures for mass spectrometry. Nature. 2007;449:1033–U1033. doi: 10.1038/nature06195. [DOI] [PubMed] [Google Scholar]
- 30.Shen ZX, et al. Porous silicon as a versatile platform for laser desorption/ionization mass spectrometry. Anal. Chem. 2001;73:612–619. doi: 10.1021/ac000746f. [DOI] [PubMed] [Google Scholar]
- 31.Takats Z, Wiseman JM, Gologan B, Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science. 2004;306:471–473. doi: 10.1126/science.1104404. [DOI] [PubMed] [Google Scholar]
- 32.Wei J, Buriak JM, Siuzdak G. Desorption-ionization mass spectrometry on porous silicon. Nature. 1999;399:243–246. doi: 10.1038/20400. [DOI] [PubMed] [Google Scholar]
- 33.Greving MP, Patti GJ, Siuzdak G. Nanostructure-Initiator Mass Spectrometry Metabolite Analysis and Imaging. Anal. Chem. 2011;83:2–7. doi: 10.1021/ac101565f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Nemes P, Woods AS, Vertes A. Simultaneous Imaging of Small Metabolites and Lipids in Rat Brain Tissues at Atmospheric Pressure by Laser Ablation Electrospray Ionization Mass Spectrometry. Anal. Chem. 2010;82:982–988. doi: 10.1021/ac902245p. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Wiseman JM, Ifa DR, Song QY, Cooks RG. Tissue imaging at atmospheric pressure using desorption electrospray ionization (DESI) mass spectrometry. Angewandte Chemie-International Edition. 2006;45:7188–7192. doi: 10.1002/anie.200602449. [DOI] [PubMed] [Google Scholar]
- 36.Yanes O, et al. Nanostructure Initiator Mass Spectrometry: Tissue Imaging and Direct Biofluid Analysis. Anal. Chem. 2009;81:2969–2975. doi: 10.1021/ac802576q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Korte AR, Stopka SA, Morris N, Razunguzwa T, Vertes A. Large-Scale Metabolite Analysis of Standards and Human Serum by Laser Desorption Ionization Mass Spectrometry from Silicon Nanopost Arrays. Anal. Chem. 2016;88:8989–8996. doi: 10.1021/acs.analchem.6b01186. [DOI] [PubMed] [Google Scholar]
- 38.Stopka SA, et al. Molecular Imaging of Biological Samples on Nanophotonic Laser Desorption Ionization Platforms. Angew. Chem. Int. Ed. 2016;55:4482–4486. doi: 10.1002/anie.201511691. [DOI] [PubMed] [Google Scholar]
- 39.Walker BN, Stolee JA, Pickel DL, Retterer ST, Vertes A. Tailored Silicon Nanopost Arrays for Resonant Nanophotonic Ion Production. Journal of Physical Chemistry C. 2010;114:4835–4840. doi: 10.1021/jp9110103. [DOI] [Google Scholar]
- 40.Walker BN, Stolee JA, Vertes A. Nanophotonic Ionization for Ultratrace and Single-Cell Analysis by Mass Spectrometry. Anal. Chem. 2012;84:7756–7762. doi: 10.1021/ac301238k. [DOI] [PubMed] [Google Scholar]
- 41.Fincher JA, et al. Matrix-free mass spectrometry imaging of mouse brain tissue sections on silicon nanopost arrays. J. Comp. Neurol. 2018;2018:1–21. doi: 10.1002/cne.24566. [DOI] [PubMed] [Google Scholar]
- 42.Jemec GBE. Hidradenitis Suppurativa. New Engl. J. Med. 2012;366:158–164. doi: 10.1056/NEJMcp1014163. [DOI] [PubMed] [Google Scholar]
- 43.Ring HC, Emtestam L. The Microbiology of Hidradenitis Suppurativa. Dermatol. Clin. 2016;34:29–35. doi: 10.1016/j.det.2015.08.010. [DOI] [PubMed] [Google Scholar]
- 44.Zouboulis CC, et al. Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation. Dermatology. 2015;231:184–190. doi: 10.1159/000431175. [DOI] [PubMed] [Google Scholar]
- 45.Wlodarek K, Ponikowska M, Matusiak L, Szepietowski JC. Biologics for hidradenitis suppurativa: an update. Immunotherapy. 2019;11:45–59. doi: 10.2217/imt-2018-0090. [DOI] [PubMed] [Google Scholar]
- 46.Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: A comprehensive review. J. Am. Acad. Dermatol. 2009;60:539–561. doi: 10.1016/j.jaad.2008.11.911. [DOI] [PubMed] [Google Scholar]
- 47.Guet-Revillet H, et al. Bacterial Pathogens Associated with Hidradenitis Suppurativa, France. Emerging Infect. Dis. 2014;20:1990–1998. doi: 10.3201/eid2012.140064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ring HC, et al. Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br. J. Dermatol. 2017;176:993–1000. doi: 10.1111/bjd.15007. [DOI] [PubMed] [Google Scholar]
- 49.Smith Mallory K, Nicholson Cynthia L, Parks-Miller Angela, Hamzavi Iltefat H. Hidradenitis suppurativa: an update on connecting the tracts. F1000Research. 2017;6:1272. doi: 10.12688/f1000research.11337.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Alvarez HM, Steinbuchel A. Triacylglycerols in prokaryotic microorganisms. Appl. Microbiol. Biotechnol. 2002;60:367–376. doi: 10.1007/s00253-002-1135-0. [DOI] [PubMed] [Google Scholar]
- 51.Pierce, C. Y. et al. Ambient generation of fatty acid methyl ester ions from bacterial whole cells by direct analysis in real time (DART) mass spectrometry. Chem. Commun., 807–809, 10.1039/b613200f (2007). [DOI] [PubMed]
- 52.Cody RB, McAlpin CR, Cox CR, Jensen KR, Voorhees KJ. Identification of bacteria by fatty acid profiling with direct analysis in real time mass spectrometry. Rapid Commun. Mass Spectrom. 2015;29:2007–2012. doi: 10.1002/rcm.7309. [DOI] [PubMed] [Google Scholar]
- 53.Jenkins B, West JA, Koulman A. A Review of Odd-Chain Fatty Acid Metabolism and the Role of Pentadecanoic Acid (C15:0) and Heptadecanoic Acid (C17:0) in Health and Disease. Molecules. 2015;20:2425–2444. doi: 10.3390/molecules20022425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Vlaeminck B, Fievez V, Cabrita ARJ, Fonseca AJM, Dewhurst RJ. Factors affecting odd- and branched-chain fatty acids in milk: A review. Anim. Feed Sci. Technol. 2006;131:389–417. doi: 10.1016/j.anifeedsci.2006.06.017. [DOI] [Google Scholar]
- 55.Whittaker P, et al. Use of fatty acid profiles to identify food-borne bacterial pathogens and aerobic endospore-forming bacilli. J. Agric. Food. Chem. 2005;53:3735–3742. doi: 10.1021/jf040458a. [DOI] [PubMed] [Google Scholar]
- 56.Tan, C. Y. et al. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance. Sci. Rep., 5, 10.1038/srep18366 (2015). [DOI] [PMC free article] [PubMed]
- 57.Hannun YA, Luberto C, Argraves KM. Enzymes of sphingolipid metabolism: From modular to integrative signaling. Biochemistry. 2001;40:4893–4903. doi: 10.1021/bi002836k. [DOI] [PubMed] [Google Scholar]
- 58.Luberto C, Hannun YA. Sphingolipid metabolism in the regulation of bioactive molecules. Lipids. 1999;34:S5–S11. doi: 10.1007/bf02562221. [DOI] [PubMed] [Google Scholar]
- 59.Obeid LM, Linardic CM, Karolak LA, Hannun YA. PROGRAMMED CELL-DEATH INDUCED BY CERAMIDE. Science. 1993;259:1769–1771. doi: 10.1126/science.8456305. [DOI] [PubMed] [Google Scholar]
- 60.Heung LJ, Luberto C, Del Poeta M. Role of sphingolipids in microbial pathogenesis. Infect. Immun. 2006;74:28–39. doi: 10.1128/iai.74.1.28-39.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Becam, J. et al. Antibacterial activity of ceramide and ceramide analogs against pathogenic Neisseria. Sci. Rep., 7, 10.1038/s41598-017-18071-w (2017). [DOI] [PMC free article] [PubMed]
- 62.Drake DR, Brogden KA, Dawson DV, Wertz PW. Thematic review series: Skin lipids - Antimicrobial lipids at the skin surface. J. Lipid Res. 2008;49:4–11. doi: 10.1194/jlr.R700016-JLR200. [DOI] [PubMed] [Google Scholar]
- 63.Fischer CL, et al. The roles of cutaneous lipids in host defense. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids. 2014;1841:319–322. doi: 10.1016/j.bbalip.2013.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Uchida Y. Ceramide signaling in mammalian epidermis. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids. 2014;1841:453–462. doi: 10.1016/j.bbalip.2013.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Seitz AP, Grassme H, Edwards MJ, Pewzner-Jung Y, Gulbins E. Ceramide and sphingosine in pulmonary infections. Biol. Chem. 2015;396:611–620. doi: 10.1515/hsz-2014-0285. [DOI] [PubMed] [Google Scholar]
- 66.Nakayama H, Nagafuku M, Suzuki A, Iwabuchi K, Inokuchi JI. The regulatory roles of glycosphingolipid-enriched lipid rafts in immune systems. FEBS Lett. 2018;592:3921–3942. doi: 10.1002/1873-3468.13275. [DOI] [PubMed] [Google Scholar]
- 67.Furukawa K, et al. Regulatory function of glycosphingolipids in the inflammation and degeneration. Arch. Biochem. Biophys. 2015;571:58–65. doi: 10.1016/j.abb.2015.02.007. [DOI] [PubMed] [Google Scholar]
- 68.Iwabuchi Kazuhisa, Nakayama Hitoshi, Oizumi Ami, Suga Yasushi, Ogawa Hideoki, Takamori Kenji. Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans. Mediators of Inflammation. 2015;2015:1–10. doi: 10.1155/2015/120748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Iwabuchi K, et al. Properties and functions of lactosylceramide from mouse neutrophils. Glycobiology. 2015;25:655–668. doi: 10.1093/glycob/cwv008. [DOI] [PubMed] [Google Scholar]
- 70.Dany M, Elston D. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa. J. Am. Acad. Dermatol. 2017;77:268. doi: 10.1016/j.jaad.2017.03.016. [DOI] [PubMed] [Google Scholar]
- 71.Goetzl EJ, Rosen H. Regulation of immunity by lysosphingolipids and their G protein - coupled receptors. Journal of Clinical Investigation. 2004;114:1531–1537. doi: 10.1172/jci200423704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Goetzl EJ, Kong Y, Voice JK. Cutting edge: Differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. Journal of Immunology. 2000;164:4996–4999. doi: 10.4049/jimmunol.164.10.4996. [DOI] [PubMed] [Google Scholar]
- 73.Morris NJ, et al. Laser desorption ionization (LDI) silicon nanopost array chips fabricated using deep UV projection lithography and deep reactive ion etching. Rsc Advances. 2015;5:72051–72057. doi: 10.1039/c5ra11875a. [DOI] [Google Scholar]
- 74.Strohalm M, Kavan D, Novak P, Volny M, Havlicek V. mMass 3: A Cross-Platform Software Environment for Precise Analysis of Mass Spectrometric Data. Anal. Chem. 2010;82:4648–4651. doi: 10.1021/ac100818g. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.